1. Home
  2. Blog
  3. UPSC

InfexnTM

Why is it in the news?

  • The introduction of ‘InfexnTM’ marks a transformative shift in Kerala’s medical landscape as India’s first genomics-based infectious disease test, leveraging next-generation sequencing technology.

 About InfexnTM

  • InfexnTM is a state-of-the-art targeted next-generation sequencing test developed by IIT-Bombay-based HaystackAnalytics and NIMS Medicity at Neyyattinkara.
  • The primary objective of InfexnTM is to detect bacterial and/or fungal infections, along with identifying relevant antimicrobial resistance genes, all within a timeframe of 24 hours.

Features:

  • InfexnTM is a comprehensive kit-cum-software solution designed to be used within hospital settings.
  • It is proudly labelled as a “Made in India, Made for the World” test, showcasing its indigenous development and global applicability.

 Significance

  • Empowerment of Healthcare Ecosystem: InfexnTM promises to empower the healthcare ecosystem with advanced and definitive diagnostics, thereby facilitating optimal antibiotic usage.
  • Championing Antimicrobial Leadership: Its introduction aligns with the national goal of championing antimicrobial leadership, crucial for combating the rise of antimicrobial resistance.
  • Enhanced Accuracy and Efficiency: InfexnTM’s innovative approach is expected to enhance the accuracy and efficiency of infectious disease detection, enabling timely and precise diagnosis.
  • Improved Patient Outcomes: By providing clinicians with efficient and accurate diagnoses of infectious diseases, InfexnTM facilitates targeted therapy and ultimately leads to improved patient outcomes.
  • Life-saving Potential: The timely generation of InfexnTM reports can be life-saving for patients with suspected infections, allowing for prompt initiation of appropriate treatment strategies.

Get free UPSC Updates straight to your inbox!

Discover more from AMIGOS IAS

Subscribe now to keep reading and get access to the full archive.

Continue reading